What a fantastic read. And patent protected to 2044. Well done ANP.
Families can now be confident that even if their son has received the one off gene therapy treatment, their so can still benefit from ATL1102. This is real hope, something these families haven't had prior to this.
For ANP holders it means ATL 1102 has potential for 100% of DMD boys, once non-ambulant and ambulant cohorts are cleared.
Perhaps starting ATL1102 at an earlier age, like the gene therapy, could prevent fibrosis damage from starting?
Awesome news for DMD families.
I see a couple of old hands havevdaid they wont participate in the SPP, but I think this will attract many other holders. Roll back probably a certainty now.
- Forums
- ASX - By Stock
- PER
- Ann: Positive new DMD Combination Therapy Data in mdx mice
Ann: Positive new DMD Combination Therapy Data in mdx mice, page-7
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
0.004(4.65%) |
Mkt cap ! $81.13M |
Open | High | Low | Value | Volume |
8.6¢ | 9.1¢ | 8.5¢ | $181.6K | 2.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10344 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 64275 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.085 |
2 | 155000 | 0.084 |
1 | 150000 | 0.083 |
1 | 36585 | 0.082 |
3 | 43077 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 64275 | 1 |
0.091 | 106821 | 1 |
0.092 | 50000 | 1 |
0.094 | 160000 | 1 |
0.095 | 550000 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online